Showing results (11-20 of 290) with videos related to
Sort By:
Pageof 29
Hematology/Oncology Clinics of North America|March 30, 2011
Treating venous thromboembolism in pregnancyAnnemarie E Fogerty, Jean M ConnorsJournal of Thrombosis and Thrombolysis|June 23, 2019
Cost-effectiveness of edoxaban versus dalteparin for the treatment of cancer-associated thrombosisNathan T Connell, Jean M ConnorsFuture Cardiology|October 25, 2018
Betrixaban in the prevention of venous thromboembolism in medically ill patientsKatelyn W Sylvester, Jean M ConnorsBlood Advances|November 27, 2019
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyHanny Al-Samkari, Jean M ConnorsThe Oncologist|December 10, 2013
New oral anticoagulants and the cancer patientNicholas J Short, Jean M ConnorsClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 15, 2015
The Role of Anticoagulants in the Prevention of Pregnancy ComplicationsRebecca Karp Leaf, Jean M ConnorsCancers|August 17, 2018
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated ThrombosisHanny Al-Samkari, Jean M ConnorsHematology. American Society of Hematology. Education Program|December 7, 2019
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyHanny Al-Samkari, Jean M ConnorsCurrent Opinion in Hematology|August 3, 2020
Venous thromboembolism in the hormonal milieuNathan T Connell, Jean M ConnorsInternal and Emergency Medicine|May 25, 2023
Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receiveMelina Verso, Andres Muñoz, Jean M ConnorsPageof 29